Efficacy of L-Ornithine L-Aspartate in Acute Liver Failure: A Double-Blind, Randomized, Placebo-Controlled Study

Gastroenterology

Volumn 136, Issue 7, 2009, Pages 2159-2168

  Acharya, Subrat Kumar ^a   Bhatia, Vikram ^a   Sreenivas, Vishnubhatla ^a   Khanal, Shankar ^a   Panda, Subrat Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ORNITHINE ASPARTATE; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFUSION; KIDNEY FAILURE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE;

EID: 66149127267     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.02.050     Document Type: Article

References (30)

1. Strauss G.I., Knudsen G.M., Kondrup J., et al. Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure. Gastroenterology 121 (2001) 1109-1119
2. Chatauret N., and Butterworth R. Effects of liver failure on inter-organ trafficking of ammonia: implications for the treatment of hepatic encephalopathy. J Gastroenterol Hepatol 19 (2004) S219-S223
3. Jones E.A. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy. Metab Brain Dis 17 (2002) 275-281
4. Clemmesen J.O., Larsen F.S., Kondrup J., et al. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29 (1999) 648-653
5. Kundra A., Jain A., Banga A., et al. Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension. Clin Biochem 38 (2005) 696-699
6. Bhatia V., Singh R., and Acharya S.K. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55 (2006) 98-104
7. Bernal W., Hall C., Karvellas C.J., et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 46 (2007) 1844-1852
8. Zieve L., Lyftogt C., and Raphael D. Ammonia toxicity: comparative protective effect of various arginine and ornithine derivatives, aspartate, benzoate and carbamyl glutamate. Metab Brain Dis 1 (1986) 25-35
9. Albrecht J., Hilgier W., Januszewski S., et al. Increase of the brain uptake index for L-ornithine in rats with hepatic encephalopathy. Neuroreport 5 (1994) 671-673
10. Rose C., Michalak A., Pannunzio P., et al. L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action. Metab Brain Dis 13 (1998) 147-157
11. Kircheis G., Wettstein M., Dahl S., et al. Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. Metab Brain Dis 17 (2002) 453-462
12. Rose C., Michalak A., Rao K.V., et al. L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatology 30 (1999) 636-640
13. Tandon B.N., Bernauau J., Grady J., et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and sub acute liver failure. J Gastroenterol Hepatol 14 (1999) 403-404
14. Altman D.G., Schulz K.F., Moher D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 (2001) 663-694
15. Acharya S.K., Dasarathy S., Kumer T.L., et al. Fulminant hepatitis in a tropical population: clinical course, cause and early predictors of outcome. Hepatology 23 (1996) 1448-1455
16. Jameel S., Durgapal H., Habibullah C.M., et al. Enteric non-A, non-B hepatitis: epidemics, animal transmission, and hepatitis E virus detection by the polymerase chain reaction. J Med Virol 37 (1992) 263-270
17. Riegler J.L., and Lake J.R. Fulminant hepatic failure. Med Clin North Am 77 (1993) 1057-1083
18. Staedt U., Leweling H., Gladisch R., et al. Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design. J Hepatol 19 (1993) 424-430
19. Kircheis G., Nilius R., Held C., et al. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 25 (1997) 1351-1360
20. Stauch S., Kircheis G., Adler G., et al. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol 28 (1998) 856-864
21. Poo J.L., Góngora J., Sánchez-Avila F., et al. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study. Ann Hepatol 5 (2006) 281-288
22. Clemmesen J.O., Kondrup J., and Ott P. Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 118 (2000) 1131-1139
23. Rosen H.M., Yoshimura N., Hodgman J.M., et al. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 72 (1977) 483-487
24. Clemmesen J.O., Kondrup J., Nielsen L.B., et al. Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol 96 (2001) 1217-1223
25. Rees C.J., Oppong K., Al Mardini H., et al. Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. Gut 47 (2000) 571-574
26. Alba L., Hay J.E., Angulo P., et al. Lactulose therapy in acute liver failure. J Hepatol 36 (2002) 33A
27. Polson J., and Lee W.M. AASLD position paper: the management of acute liver failure. Hepatology 41 (2005) 1179-1197
28. Sushma S., Dasarathy S., Tandon R.K., et al. Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial. Hepatology 16 (1992) 138-144
29. Efrati C., Masini A., Merli M., et al. Effect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: a note of caution. Am J Gastroenterol 95 (2000) 3574-3578
30. Palekar A.G., Canas J.A., Kalbag S.S., et al. Failure of sodium benzoate to alleviate plasma and liver ammonia in rats. Biochem Med Metab Biol 41 (1989) 64-69